CCEL stock forecast
Our latest prediction for Cryo-Cell International, Inc.'s stock price was made on the Aug. 10, 2020 when the stock price was at 9.10$.
In the short term (2weeks), CCEL's stock price should outperform the market by 0.59%. During that period the price should oscillate between -7.43% and +6.96%.
In the medium term (3months), CCEL's stock price should underperform the market by -4.84%. During that period the price should oscillate between -25.06% and +18.35%.
Get email alertsCreate a solid portfolio with CCEL
About Cryo-Cell International, Inc.
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation service and to advance regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage; and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded on September 11, 1989 and is headquartered in Oldsmar, FL.
At the moment the company generates 32M USD in revenues.
On its last earning announcement, the company reported a profit of 0.43$ per share.
The book value per share is -1.26$
Three months stock forecastAug. 10, 2020
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32M | 68.70% | 7M | 20.90% | 4M | 0.43 | - | - | 8M | -1.26 | 7M | - | 7M |